U.S. Pharmaceutical Sales - Q1 2012
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q1 2012 by sales
Rank |
Drug |
Sales ($000) |
|
|
1 ( 1) |
Plavix
|
1,620,790 |
2.85% |
Stats |
2 ( 1) |
Nexium AstraZeneca |
1,395,981 |
-3.08% |
Stats |
3 ( 1) |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,340,200 |
4.46% |
Stats |
4 ( 1) |
Singulair Merck |
1,238,134 |
8.67% |
Stats |
5 ( 1) |
Seroquel AstraZeneca |
1,161,141 |
3.29% |
Stats |
6 ( 1) |
Advair Diskus GlaxoSmithKline |
1,139,182 |
1.61% |
Stats |
7 ( 1) |
Crestor AstraZeneca |
1,117,904 |
2.35% |
Stats |
8 ( 1) |
Cymbalta
|
1,029,262 |
7.58% |
Stats |
9 ( 15) |
atorvastatin Generic |
952,407 |
88.56% |
Stats |
10 |
Humira AbbVie Inc. |
928,124 |
2.50% |
Stats |
11 ( 2) |
Remicade Janssen Pharmaceuticals, Inc. |
899,453 |
10.04% |
Stats |
12 ( 1) |
Enbrel Amgen Inc. |
890,135 |
1.92% |
Stats |
13 ( 1) |
Neulasta Amgen Inc. |
849,971 |
3.33% |
Stats |
14 ( 13) |
Lipitor
|
840,715 |
-47.51% |
Stats |
15 ( 1) |
Rituxan Genentech, Inc. |
756,875 |
-1.91% |
Stats |
16 |
Copaxone Teva Pharmaceuticals USA, Inc. |
748,585 |
4.59% |
Stats |
17 ( 2) |
Atripla Gilead Sciences, Inc. |
694,901 |
5.61% |
Stats |
18 ( 1) |
OxyContin Purdue Pharma LP |
662,876 |
-1.05% |
Stats |
19 ( 3) |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
659,818 |
8.12% |
Stats |
20 ( 1) |
Avastin Genentech, Inc. |
632,183 |
-1.92% |
Stats |
21 ( 3) |
Actos Takeda Pharmaceutical Company Limited |
630,970 |
-4.52% |
Stats |
22 ( 1) |
Januvia Merck |
583,603 |
7.89% |
Stats |
23 ( 2) |
Truvada Gilead Sciences, Inc. |
546,098 |
8.31% |
Stats |
24 ( 3) |
Lantus Sanofi |
520,584 |
9.78% |
Stats |
25 ( 3) |
Diovan Novartis Pharmaceuticals Corporation |
509,615 |
12.44% |
Stats |
26 ( 11) |
Lexapro
|
491,053 |
-31.67% |
Stats |
27 ( 7) |
Epogen Amgen Inc. |
489,570 |
-24.54% |
Stats |
28 ( 3) |
Lyrica
|
458,171 |
6.04% |
Stats |
29 ( 5) |
Lantus Solostar Sanofi |
448,388 |
9.81% |
Stats |
30 ( 4) |
enoxaparin Generic |
442,263 |
-8.30% |
Stats |
31 ( 4) |
Eloxatin Sanofi |
431,928 |
8.38% |
Stats |
32 |
Celebrex
|
430,993 |
1.08% |
Stats |
33 |
Herceptin Genentech, Inc. |
425,687 |
-0.06% |
Stats |
34 ( 6) |
Diovan HCT Novartis Pharmaceuticals Corporation |
415,475 |
9.52% |
Stats |
35 ( 5) |
Lucentis Genentech, Inc. |
409,547 |
-6.89% |
Stats |
36 ( 15) |
Synagis MedImmune, Inc. |
396,556 |
38.30% |
Stats |
37 |
Namenda
|
391,638 |
2.71% |
Stats |
38 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
391,072 |
0.13% |
Stats |
39 ( 1) |
Avonex Biogen Inc. |
388,623 |
2.22% |
Stats |
40 ( 3) |
Vyvanse Takeda Pharmaceutical Company Limited |
387,167 |
11.05% |
Stats |
41 ( 2) |
olanzapine Generic |
385,867 |
1.70% |
Stats |
42 ( 13) |
Incivek Vertex Pharmaceuticals Incorporated |
371,349 |
-16.88% |
Stats |
43 ( 1) |
OneTouch
|
366,294 |
1.32% |
Stats |
44 |
Suboxone
|
338,840 |
2.14% |
Stats |
45 ( 5) |
methylphenidate Generic |
337,211 |
11.27% |
Stats |
46 |
Zetia Merck |
328,653 |
2.67% |
Stats |
47 ( 6) |
AndroGel AbbVie Inc. |
311,850 |
11.20% |
Stats |
48 ( 1) |
Provigil
|
303,029 |
-3.18% |
Stats |
49 |
Lidoderm Endo Pharmaceuticals Inc. |
301,354 |
-2.46% |
Stats |
50 ( 2) |
TriCor AbbVie Inc. |
298,834 |
-4.37% |
Stats |
51 ( 5) |
Symbicort AstraZeneca |
290,669 |
8.71% |
Stats |
52 |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
285,487 |
1.08% |
Stats |
53 ( 16) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
284,647 |
18.08% |
Stats |
54 ( 5) |
Seroquel XR AstraZeneca |
282,416 |
7.81% |
Stats |
55 ( 1) |
amphetamine/dextroamphetamine Generic |
275,447 |
-1.02% |
Stats |
56 ( 8) |
Nasonex Merck |
274,748 |
9.21% |
Stats |
57 ( 6) |
Novolog Novo Nordisk |
266,305 |
5.67% |
Stats |
58 ( 3) |
Procrit Janssen Pharmaceuticals, Inc. |
264,190 |
-2.13% |
Stats |
59 ( 1) |
Alimta Eli Lilly and Company |
263,024 |
1.24% |
Stats |
60 ( 2) |
Viagra
|
260,678 |
1.22% |
Stats |
61 ( 16) |
Geodon
|
260,514 |
-21.06% |
Stats |
62 ( 1) |
Rebif EMD Serono, Inc. |
258,088 |
-0.21% |
Stats |
63 ( 6) |
budesonide Generic |
257,243 |
-3.57% |
Stats |
64 ( 6) |
Niaspan AbbVie Inc. |
255,383 |
-3.28% |
Stats |
65 |
Humalog Eli Lilly and Company |
244,587 |
-2.70% |
Stats |
66 ( 1) |
Flovent HFA GlaxoSmithKline |
241,552 |
-1.45% |
Stats |
67 ( 1) |
Lovaza GlaxoSmithKline |
239,845 |
-1.81% |
Stats |
68 ( 7) |
Levemir Novo Nordisk |
239,576 |
9.25% |
Stats |
69 ( 5) |
Adderall XR Takeda Pharmaceutical Company Limited |
239,097 |
5.88% |
Stats |
70 |
Neupogen Amgen Inc. |
238,427 |
0.06% |
Stats |
71 ( 1) |
Reyataz Bristol-Myers Squibb Company |
238,151 |
1.45% |
Stats |
72 ( 6) |
Aranesp Amgen Inc. |
231,643 |
-5.86% |
Stats |
73 |
metoprolol Generic |
231,395 |
-0.53% |
Stats |
74 ( 2) |
NovoLog FlexPen Novo Nordisk |
227,228 |
8.96% |
Stats |
75 ( 4) |
Vytorin Merck |
218,215 |
-7.25% |
Stats |
76 ( 7) |
Janumet Merck |
212,596 |
8.76% |
Stats |
77 ( 1) |
Isentress Merck |
211,526 |
2.46% |
Stats |
78 ( ) |
escitalopram Generic |
210,171 |
n/a |
Stats |
79 ( 1) |
Cialis Eli Lilly and Company |
206,996 |
3.24% |
Stats |
80 ( 3) |
Aciphex Eisai Inc. |
203,097 |
-1.77% |
Stats |
81 ( 4) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
201,065 |
5.13% |
Stats |
82 ( 2) |
Solodyn Medicis Pharmaceutical Corporation |
198,909 |
2.06% |
Stats |
83 ( 4) |
fentanyl Generic |
197,350 |
-3.34% |
Stats |
84 ( 43) |
Zyprexa
|
194,460 |
-48.69% |
Stats |
85 ( 4) |
Velcade Takeda Pharmaceutical Company Limited |
188,583 |
4.42% |
Stats |
86 |
Restasis Allergan plc |
188,501 |
-1.18% |
Stats |
87 ( 5) |
Lunesta Sunovion Pharmaceuticals Inc. |
187,941 |
-4.30% |
Stats |
88 ( 1) |
acetaminophen/hydrocodone Generic |
185,374 |
0.09% |
Stats |
89 ( 9) |
Prezista Janssen Pharmaceuticals, Inc. |
182,859 |
9.20% |
Stats |
90 ( 1) |
Pegasys Genentech, Inc. |
181,693 |
3.92% |
Stats |
91 ( 2) |
Zyvox Pfizer Inc. |
179,523 |
3.85% |
Stats |
92 ( 4) |
Prevnar 13 Pfizer Inc. |
179,085 |
-1.16% |
Stats |
93 ( 12) |
Lovenox Sanofi |
178,957 |
-9.21% |
Stats |
94 |
Benicar Daiichi Sankyo |
174,619 |
2.79% |
Stats |
95 ( 5) |
VESIcare Astellas Pharma US, Inc. |
174,524 |
6.58% |
Stats |
96 ( ) |
Ventolin HFA GlaxoSmithKline |
172,707 |
n/a |
Stats |
97 ( ) |
Orencia Bristol-Myers Squibb Company |
172,202 |
n/a |
Stats |
98 ( 1) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
172,143 |
2.93% |
Stats |
99 ( 2) |
Erbitux Eli Lilly and Company |
171,513 |
2.30% |
Stats |
100 ( ) |
Dexilant Takeda Pharmaceutical Company Limited |
171,179 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.